Bortezomib and Low-Dose Dexamethasone with or Without Continuous Low-Dose Oral Cyclophosphamide for Primary Refractory or Relapsed Multiple Myeloma: a Randomized Phase III Study
Blood(2014)
关键词
Multiple myeloma,Phase III,Bortezomib,Cyclophosphamide,Relapsed/refractory
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要